Compass Therapeutics Inc (CMPX) Company Sales

Risks for Compass Therapeutics (CMPX) are linked to a high burn rate and uncertainty regarding test outcomes. The company's product revenue reflects a trend where the current level is around 0.00. Experienced scientists are effectively coordinating antibody development, while a cautiously positive brand image within the investment community is supported by clinical trial results.

compasstherapeutics.com (CMPX): Company Revenue from 07/04/2022 to 11/13/2026

Analytical breakdowns for Compass Therapeutics, Inc. (CMPX)

- stock value and consensus price forecast:

Stock Quotes Compass Therapeutics Corp|CMPX - Price Target Chart

- market capitalization details:

Market Valuation Compass Therapeutics, Inc.|CMPX - Real Price to Acquire Entire Company

- balance sheet equity data:

Book Value per Share Compass Therapeutics|CMPX - Company Book Value|Capitalization to Book Value Ratio compasstherapeutics.com|CMPX - Aggregate Company Assets

- debt obligations and liquidity statistics:

Debt to Capital Compass Therapeutics|CMPX - Long-Term Debt to Equity Ratio|Short-Term Indebtedness to Equity Compass Therapeutics Inc|CMPX - Company Total Debt|Debt to Book Capital Compass Therapeutics, Inc.|CMPX - Company Long-Term Debts|Company Short-Term Loans and Borrowings Compass Therapeutics|Immediate Liquidity compasstherapeutics.com

- net income and valuation ratios data:

CMPX - Company Net Income|Expected Net Income Compass Therapeutics|CMPX - P/E Multiple|Forward P/E Multiple compasstherapeutics.com|CMPX - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Compass Therapeutics, Inc.|CMPX - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Compass Therapeutics|CMPX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months compasstherapeutics.com|CMPX - Earnings per share growth in current year|Expected net earnings per share growth next year Compass Therapeutics

- sales volume and revenue indicators:

CMPX - Company Revenue|Company Future Sales Volume Compass Therapeutics Corp|CMPX - Price-to-Revenue Ratio|Future Price to Revenue Compass Therapeutics, Inc.

General company analysis:Compass Therapeutics Corp, CMPX

Original product of Compass Therapeutics, Inc.

The development of immuno-oncology drugs by Compass Therapeutics (CMPX) is characterized by a lack of seasonality and no macroeconomic dependence on demand. In this context, the company's trading revenue dynamics reflect actual cash inflows from clients, neutralizing short-term market fluctuations. This metric captures the business's fundamental ability to monetize its developments. Analyzing this indicator allows for the separation of random spikes from sustainable growth. Investors utilize this indicator to assess the operational viability of the asset.

Key competitors